Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre

Cheeseman, S, Thompson, M, Sopwith, W et al. (18 more authors) (2020) Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre. Frontiers in Oncology, 10. 167.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020 Cheeseman, Thompson, Sopwith, Godden, Seshagiri, Adedokun, Zucker, Jain, Kotwal, Prescott, Henry, Joseph, Chilka, Roulson, Weston, Burbidge, Brown, Jagdev, Ralph, Hall and Vasudev. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Keywords: carboplatin, cisplatin, real-world, chemotherapy, urothelial cancer
Dates:
  • Published: 20 February 2020
  • Accepted: 30 January 2020
  • Published (online): 20 February 2020
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 16 Apr 2020 11:11
Last Modified: 16 Apr 2020 11:11
Status: Published
Publisher: Frontiers Media SA
Identification Number: https://doi.org/10.3389/fonc.2020.00167

Share / Export

Statistics